Decrease in Attendance: TPE24 Opens with Fewer Visitors

Events by 2FIRSTS

Feb.01.2024

Decrease in Attendance: TPE24 Opens with Fewer Visitors

TPE24, the largest tobacco exhibition in North America, opened in Las Vegas with noticeably fewer attendees compared to previous years.

On January 31st, TPE24, the largest tobacco exhibition in North America, officially opened in Las Vegas. However, several exhibitors have expressed that compared to previous years' bustling first day, TPE24 noticeably had a reduced number of attendees.

A visitor compared TPE24 to previous editions and noted that it had the largest exhibition scale. However, the attendance on the opening day was even lower than the attendance on the last day of past editions.

According to the information received, the visitation process at TPE24 is more stringent compared to previous years, as attendees are now required to provide enterprise certification. This signifies that the current exhibition is not open to individual consumers. This particular measure has contributed to a decrease in the number of visitors.

Also Read:

[1] FDA Participates in TPE24 to Promote Regulations and Policies

[2] TPE24: Full-Screen, Fast Charging, 20,000mAh Battery – Sneak Peek at Highlight Products

[3] TPE24: FDA will Participate and Set up Booth in Vape Area

[4] Predicted Highlights for TPE24: Product, Brand, Marketing Trends

[5] TPE 2024 Spotlight: Nearly 100 Global E-Cig Brands in Attendance

[6] TPE 2024: List of More than 30 Vape Distributors from North America

[7] TPE24: Exclusive Preview of the Exhibition Site | Live Photo Gallery

#North America #United States #Traditional tobacco #Market #TPE2024

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.

Nov.14 by 2FIRSTS.ai

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st

Oct.21

Bangladesh Tobacco Control Group Urges Reversal of Philip Morris Nicotine Pouch Factory Approval

Advocates say the economic authority’s decision contradicts national health goals and violates a Supreme Court directive banning new tobacco ventures.

Oct.27 by 2FIRSTS.ai

Ireland to Impose EU’s Highest Tax on Vape E-Liquids: €0.50 per ml, Effective Nov. 1

From Nov. 1, Ireland will levy €0.50/ml on all e-liquids and tighten rules—including a disposable ban; advocates warn this could hinder quitting amid a missed 2025 target.